Results 141 to 150 of about 2,596 (228)

The Impact of the COVID-19 Pandemic on Case Volume and Wait Times of Elective Hand Procedures: A Retrospective Chart Review Study. [PDF]

Plast Surg (Oakv)
Uhlman K, Churchill I, Dydynsky R, Johnston S, Leveille C, McRae M, McRae M.   +6 more
europepmc   +1 more source

Dupuytren's Disease Percutaneous Needle Aponeurotomy: Does Grip Strength Improve Post Procedure? [PDF]

J Clin Med
Medland J, Garcia N, Seth I, Rozen WM.
europepmc   +1 more source

Mini-Open Partial Fasciotomy for Dupuytren Contracture: Time to Reintervention. [PDF]

Hand (N Y)
Lans J, Beagles C, Luan A, Mehta M, Gatta J, Mudgal C.   +5 more
europepmc   +1 more source

Treatment utilization for Dupuytren's contracture in the United States is influenced by socioeconomic factors. [PDF]

J Hand Surg Eur Vol
Zhuang T, Berns EM, Lee HH.
europepmc   +1 more source

Appropriate randomization, adherence to Ethics board approved trial protocol and transparent reporting of amendments and exclusions define RCT integrity. [PDF]

EFORT Open Rev
Eckerdal D, Pakosta H, Ali M, Atroshi I.
europepmc   +1 more source

Running Z-Plasty in Selective Fasciectomy.

Deutsches Arzteblatt international, 2022
openaire   +1 more source

A Rare Case of Necrotizing Fasciitis Presenting As Tarsal Tunnel Syndrome in a Patient With Uncontrolled Diabetes. [PDF]

Cureus
Parmar J.
europepmc   +1 more source

Long-term recurrence of Dupuytren's disease treated with clostridium histolitycum collagenase. Surgical treatment and anatomopathological study. [PDF]

Arch Orthop Trauma Surg
Simón-Pérez C, Rodríguez-Mateos JI, Maestro IA, Alvarez-Quiñones M, Simon-Perez E, Martín-Ferrero MA.   +5 more
europepmc   +1 more source

Challenges and innovations in the surgical treatment of advanced Dupuytren disease by percutaneous needle fasciotomy: indications, limitations, and medico-legal implications. [PDF]

J Orthop Surg Res
Basile G, Amadei F, Prevot LB, Tronconi LP, Ciccarelli A, Bolcato V, Zaami S.   +6 more
europepmc   +1 more source